ORCHID CHEM concern about future growth looms http://akprabhakar.blogspot.com/2009/12/orchid-chem-concern-about-future-growth.html *GLENMARK and JUBILANT Organosys which can see better performance in years to come.***
ORCHIDCHEM Cmp Rs.199 saw sudden sell-off with volumes after, Orchid Chemicals & Pharmaceuticals has agreed to sell its injectables business to the US-based Hospira for around $400 million (Rs 1,850 crore), a valuation that represents a 20% premium to the Chennai-based firm’s market value and greatly boosts its financial flexibility. The acquisition includes Orchid’s beta-lactam antibiotics manufacturing complex and pharmaceutical research and development facility at Irungattukottai in Chennai and its generic injectable product portfolio and pipeline. [image: ORCHID.JPEG] Regards A.K.Prabhakar Equity Analyst [email protected] [email protected] * *http://akprabhakar.blogspot.com http://prabhakar-views.blogspot.com *Disclaimer:*** *This represents views based purely on Technical studies. The information and views presented in this report are prepared by A K Prabhakar. The information contained herein is based on my analysis of the Charts and upon sources that I consider reliable. I, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and I am not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither A K Prabhakar nor any person connected with him accepts any liability arising from the use of this information and views mentioned in this document. A K Prabhakar and his affiliates may hold long or short positions in the above-mentioned companies from time to time. The report is intended for a restricted audience and I am not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities. * -- You received this message because you are subscribed to the Google Groups ""GLOBAL SPECULATORS"" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/globalspeculators?hl=en.
<<image001.jpg>>
